OVARIAN CANCER and US

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, September 16, 2008

Prognostic implication of endometriosis in clear c...[Gynecol Oncol. 2008] - PubMed Result



Prognostic implication of endometriosis in clear c...[Gynecol Oncol. 2008] - PubMed Result

Therapy-related myeloid leukemia. [Semin Oncol. 2008] - PubMed Result



Therapy-related myeloid leukemia. [Semin Oncol. 2008] - PubMed Result

Chromosomal instability in fallopian tube precurso...[Gynecol Oncol. 2008] - PubMed Result



Chromosomal instability in fallopian tube precurso...[Gynecol Oncol. 2008] - PubMed Result

abstract: Patient Navigation: State of the art or is it science?



Wiley InterScience :: JOURNALS :: Cancer

JCO.2008 Progress in Cancer Care: The Hope, the Hype, and the Gap Between Reality and Perception



Progress in Cancer Care: The Hope,
the Hype, and the Gap Between Reality
and Perception
JCO.2008.17.6198v1.pdf (application/pdf Object)

abstract:

JCO Early Release, published online ahead of print Sep 15 2008
Journal of Clinical Oncology, 10.1200/JCO.2008.17.6198


Progress in Cancer Care: The Hope, the Hype, and the Gap Between Reality and Perception

Leonard B. Saltz

Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, and Weill Medical College of Cornell University, New York, NY

Ovarian cancer drug trial reveals promising new treatment -Ovarian Cancer news-



Ovarian cancer drug trial reveals promising new treatment -Ovarian Cancer news-

Abstract: Breast vs ovarian cancer cells' molecular profile as a response to treatment with anticancer drugs Cisplatin, Carbo, Doxil, VP15 and Taxol



HighWire Press -- Medline Abstract

The Canadian Press: Hope, confusion in hunt for ovarian cancer tests; FDA watches field closely



The Canadian Press: Hope, confusion in hunt for ovarian cancer tests; FDA watches field closely

Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors.



Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors.

The Trajectory of Psychological Impast in BRCA 1/2 Genetic Testing - Does Time Heal?



HighWire Press -- Medline Abstract

Monday, September 15, 2008

2008 Abstract: Loss of DNA Mismatch Repair Protein hMSH6 in Ovarian Cancer is Histotype-Specific



HighWire Press -- Medline Abstract

2008 abstract: The Importance of CA125 Normalization During Neoadjuvant Chemotherapy Followed by Planned Delayed Surgical Debulking in Patients



HighWire Press -- Medline Abstract

2008 Factors influencing the implementation of clinical guidelines for health care professionals: a meta-review



1472-6947-8-38.pdf (application/pdf Object)

Researchers identify cancer-causing gene in many colon cancers



Researchers identify cancer-causing gene in many colon cancers

2008 abstract: Meaning in life assessed with the SMiLE: a comparison between a cancer patient and student sample (abstract)



SpringerLink - Journal Article

Clinical Care Options Oncology - Ovarian Cancer: Expert Recap



Clinical Care Options Oncology - Ovarian Cancer: Expert Recap

Welcome to the PeerView Press Website



Welcome to the PeerView Press Website

Public engagement in setting priorities in health care -- Bruni et al. 179 (1): 15 -- Canadian Medical Association Journal



Public engagement in setting priorities in health care -- Bruni et al. 179 (1): 15 -- Canadian Medical Association Journal

Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? -- Suzuki et al. 19 (7): 1284 -- Annals of Oncology



Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? -- Suzuki et al. 19 (7): 1284 -- Annals of Oncology

The Staging of Cancer: A Retrospective and Prospective Appraisal -- Greene and Sobin 58 (3): 180 -- CA: A Cancer Journal for Clinicians



The Staging of Cancer: A Retrospective and Prospective Appraisal -- Greene and Sobin 58 (3): 180 -- CA: A Cancer Journal for Clinicians

'Futile Care': What to Do When Your Patient Insists on Chemotherapy That Likely Won’t Help: - Cancer Network



'Futile Care': What to Do When Your Patient Insists on Chemotherapy That Likely Won’t Help: - Cancer Network

Don't let the silent killer get you by the ovaries



Don't let the silent killer get you by the ovaries

We Fought Cancer And Cancer Won



We Fought Cancer…And Cancer Won

2008 Current Oncology: Presentations from the Integrating Wellness into Cancer Care Conference



2008

Decision Making in Oncology: A Review of Patient Decision Aids to Support Patient Participation -- Stacey et al. 58 (5): 293 -- CA: A Cancer Journal for Clinicians



Decision Making in Oncology: A Review of Patient Decision Aids to Support Patient Participation -- Stacey et al. 58 (5): 293 -- CA: A Cancer Journal for Clinicians

2008 June (Stein study) ACS's Studies of Cancer Survivors



Stein.pdf (application/pdf Object)

Performance of BRCA1/2 Mutation Prediction Models in Asian Americans -- Kurian et al., 10.1200/JCO.2008.16.8310 -- Journal of Clinical Oncology



Performance of BRCA1/2 Mutation Prediction Models in Asian Americans -- Kurian et al., 10.1200/JCO.2008.16.8310 -- Journal of Clinical Oncology

Subdividing Ovarian and Peritoneal Serous Carcinom...[Am J Surg Pathol. 2008] - PubMed Result



Subdividing Ovarian and Peritoneal Serous Carcinom...[Am J Surg Pathol. 2008] - PubMed Result

A phase 2, randomized, double-blind, placebo-contr...[Gynecol Oncol. 2008] - PubMed Result



A phase 2, randomized, double-blind, placebo-contr...[Gynecol Oncol. 2008] - PubMed Result

Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling -- Mullen et al. 6 (1): 93 -- Molecular Cancer Therapeutics



Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling -- Mullen et al. 6 (1): 93 -- Molecular Cancer Therapeutics

Lost In Translation? FDA Believes That LabCorp’s Ovarian Cancer Early Detection Test (OvaSure) Lacks Adequate Clinical Validation « Libby’s H*O*P*E*



Lost In Translation? FDA Believes That LabCorp’s Ovarian Cancer Early Detection Test (OvaSure) Lacks Adequate Clinical Validation « Libby’s H*O*P*E*

advocacy9.pdf (application/pdf Object)



advocacy9.pdf (application/pdf Object)

Analysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables -- Anderson et al. 26 (24): 3913 -- Journal of Clinical Oncology



Analysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables -- Anderson et al. 26 (24): 3913 -- Journal of Clinical Oncology

Cancer.Net Podcasts | Cancer.Net



Cancer.Net Podcasts | Cancer.Net

When The Patient Can't Decide: Study Looks At Physician Perspectives On Surrogate Decision-making



When The Patient Can't Decide: Study Looks At Physician Perspectives On Surrogate Decision-making

Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors -- Dal Lago et al., 10.1634/theoncologist.2007-0233 -- The Oncologist



Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors -- Dal Lago et al., 10.1634/theoncologist.2007-0233 -- The Oncologist

Advocating a Treatment, but Denied Access to It | BlueRidgeNow.com | Times-News Online | Hendersonville, NC



Advocating a Treatment, but Denied Access to It | BlueRidgeNow.com | Times-News Online | Hendersonville, NC

Medical News: No Evidence of Benefit for Ovary Removal with Hysterectomy - in OB/GYN, General OB/GYN from MedPage Today



Medical News: No Evidence of Benefit for Ovary Removal with Hysterectomy - in OB/GYN, General OB/GYN from MedPage Today

PLoS Medicine - Next Stop, Don't Block the Doors: Opening Up Access to Clinical Trials Results



PLoS Medicine - Next Stop, Don't Block the Doors: Opening Up Access to Clinical Trials Results

NEJM -- Wellness Programs and Lifestyle Discrimination -- The Legal Limits



short abstract:

NEJM -- Wellness Programs and Lifestyle Discrimination -- The Legal Limits

Undertreatment of Cancer Patients With Chemotherapy Is a Global Concern -- Lyman 4 (3): 114 -- Journal of Oncology Practice



Undertreatment of Cancer Patients With Chemotherapy Is a Global Concern -- Lyman 4 (3): 114 -- Journal of Oncology Practice

Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide Survey -- Field et al. 4 (3): 108 -- Journal of Oncology Practice



Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide Survey -- Field et al. 4 (3): 108 -- Journal of Oncology Practice

Biocompare News - New Cancer Gene Discovered



Biocompare News - New Cancer Gene Discovered

Primary Care Physicians and Oncologists Are Players on the Same Team -- Grunfeld 26 (14): 2246 -- Journal of Clinical Oncology



Primary Care Physicians and Oncologists Are Players on the Same Team -- Grunfeld 26 (14): 2246 -- Journal of Clinical Oncology

Cancer often detected in patients with unprovoked venous thromboembolism - ASCO



Cancer often detected in patients with unprovoked venous thromboembolism - ASCO

Ovarian cancers may begin in fallopian tube- msnbc.com



Ovarian cancers may begin in fallopian tube- msnbc.com

Humour can play an essential role in the most serious healthcare settings



Humour can play an essential role in the most serious healthcare settings

Monday September 15th, 2008: CANO conference presentation - Survivors' Debate: The Past Decade in Ovarian Cancer



Survivors Debate: The Past Decade in Ovarian Cancer

Pamela J. West1, Sandi Pniauskas2, Carolyn Benivegna3. 1Rouge Valley Health System, Toronto,
ON, Canada, 2No Institution - patient, Whitby, ON, Canada, 3No Institution - patient,
Novi, MI, USA.

2008 Inquiry will hear cancer warning



telegraphjournal.com - Inquiry will hear cancer warning